Skip to main content
. 2013 Apr 20;16(4):203–210. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2013.04.06

4.

66例患者的不良反应

The adverse effects of 66 patients

Group Rash (%) Diarrhea (%) Liver damage (%)
Gefitinib All 31 (62.3%) 12 (24.5%) 13 (26.5%)
Grade 3-4 6 (12.2%) 1 (2.0%) 2 (4.0%)
Erlotinib All 16 (94.1%) 12 (70.6%) 2 (11.7%)
Grade 3-4 6 (35.3%) 3 (17.6%) 0 (0)
P All 0.002 0.004 0.318
Grade 3-4 0.022 0.069
Total 47 (71.2%) 24 (36.4%) 15 (22.7%)